Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient

Vitiligo is an autoimmune skin disease presenting with areas of depigmentation. Recent reports suggest that Janus kinase (JAK) inhibitors may be an effective therapy. In this case report, we show our experience with an adolescent patient with a long history of generalized and refractory vitiligo, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Berbert Ferreira, Sineida, Berbert Ferreira, Rachel, Neves Neto, Afonso Cesar, Assef, Silvana Martins Caparroz, Scheinberg, Morton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488419/
https://www.ncbi.nlm.nih.gov/pubmed/34703426
http://dx.doi.org/10.1159/000513938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488419/
https://www.ncbi.nlm.nih.gov/pubmed/34703426
http://dx.doi.org/10.1159/000513938

Ejemplares similares